- Company Name : Nanjing KeyGen Biotech. Co. Ltd.
- About Us : Nanjing KeyGen Biotech. Co. Ltd., founded in Nov. 2000, is a high-tech company, which focuses on R&D on innovative medicines and approaches to treating cancer. The main shareholder of KeyGen is Nanjing Medical Group Co., Ltd (NMG), one of top ten strongest Chinese pharmaceutical enterprises and one of the five largest Groups in Nanjing. Nanjing KeyGen Biotech. Co. Ltd. have set up a drug discovery platform with self-regulated intellectual property KeyGen Human Genomic Regulatory Database (HGRD) that is based on the cutting-edge genomic research and bioinformatics. The innovative anti-cancer decoy oligonucleotide drug KGCGS102 have got 4 Chinese patents, 3 international patents are in application process. Based on the core-technology of KeyGen during the anti-cancer new drug development, KeyGen has developed and marketed over 1400 reagents for life science research in the fields of cell biology, molecular biology, protein research.
- Product/Service : cell apoptosis detection kits, molecular biology reagents, protein research kits, transfection reagents, cell signal transduction antibodies, cell apoptosis antibody, apoptosis inducer, TUNEL cell apoptosis detection kit, Annexin V-EGFP Cell Apoptosis Detection Kit
- Country/Region : China >
- Category : Health & Medical
- Contact Person : Mr. Wanzhou Zhao (Business Development Manager)
- Link More : China Health & Medical ,China Other Health Products
- Telephone :
- Fax :
- Address : 238 at Zhongyang road, Nanjing, Jiangsu, China
- Website : www.keygentec.com
- Business Type : Distributors/Wholesalers
